Homie A. Razavi

机构：Center for Disease Analysis · ORCID：0000-0002-2658-6930

发表论文 243 篇 · 总被引 62919 次 · h-index 60

代表论文

Addressing the High and Rising Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ) and Metabolic Dysfunction‐Associated Steatohepatitis ( MASH ): From the Growing Prevalence to Payors' Perspective (2025 · Alimentary Pharmacology & Therapeutics · 被引 56)
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies (2025 · Journal of Hepatology · 被引 28)
Modeling the health and economic impact of pharmacologic therapies for MASLD in the United States (2025 · Journal of Hepatology · 被引 23)
Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatology (2025 · JHEP Reports · 被引 7)
The Disease and Economic Burden of HBV and HCV in Ethiopia (2025 · Journal of Viral Hepatitis · 被引 6)
Bulevirtide for chronic hepatitis delta: from clinical trials to real life data: an expert opinion report (2025 · Antiviral Research · 被引 4)